Interleukin 6 (IL-6) is a pleiotropic cytokine with many physiological functions. The present study was designed to determine the expression of IL-6 and its receptor (IL-6R) in human gastric and colorectal cancers. Nine gastric- and nine colorectal cancer cell lines were analysed. The IL-6 gene was expressed in two gastric cancer cell lines and one colorectal cancer cell line; however, most of the cancer cell lines studied expressed the IL-6R gene. The level of IL-6 secretion in the gastric cancer cell lines correlated with the level of soluble IL-6R secretion, and was significantly higher (> ~100 pg/ml) than the level of IL-6 secretion in the colorectal cancer cell lines (> ~50 pg/ml). These results suggest that IL-6 may act in a paracrine fashion rather than an autocrine fashion in these cell lines.
SehgalPBGrieningerGTosatoG: Regulation of the acute phase and immune responses: interleukin-6. Ann N Y Acad Sci1989; 557: 1–583.
2.
KishimotoT: The biology of interleukin-6. Blood1989; 74: 1–10.
3.
BeckJTHsuS-MWijdenesJBatailleRKleinBVesoleD: Alleviation of systematic manifestation of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med1994; 330: 602–605.
4.
HiranoTMatsudaTTurnerMMiyasakaNBuchanGTangB: Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol1988; 18: 1797–1801.
5.
GaillardJPLiautardJKleinBBrochierJ: Major role of the soluble interleukin-6/ interleukin-6 receptor complex for the proliferation of interleukin-6-dependent human myeloma cell lines. Eur J Immunol1997; 27: 3332–3340.
6.
YawataHYasukawaKNatsukaSMurakamiMYamasakiKHibiM: Structure-function analysis of human IL-6 receptor: dissociation of amino acid residues required for IL-6-binding and for IL-6 signal transduction through gp130. EMBO J1993; 12: 1705–1712.
7.
ShaboYLotemJSachsL: Autoregulation of interleukin-6 and granulocyte-macrophage colony-stimulating factor in the differentiation of myeloid leukemic cells. Mol Cell Biol1989; 9: 4109–4112.
8.
KleinBZhangX-GJourdanMContentJHoussiauFAardenL: Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood1989; 73: 517–526.
9.
TakizawaHOhtoshiTOhtaKYamashitaNHirohataSHiraiK: Growth inhibition of human lung cancer cell lines by interleukin 6 in vitro: a possible role in tumor growth via an autocrine mechanism. Cancer Res1993; 53: 4175–4181.
10.
SiegallCBSchwabGNordanRPFitzGeraldDJPastanI: Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Cancer Res1990; 50: 7786–7788.
11.
KawanoMHiranoTMatsudaTTagaTHoriiYIwatoK: Autocrine generation and requirement of BSF-2/lL-6 for human multiple myelomas. Nature1988; 332: 83–85.
12.
KishimotoTAkiraSTagaT: Interleukin-6 and its receptor: a paradigm for cytokines. Science1992; 258: 593–597.
13.
BabaMHasegawaHNakayabuMShimizuNSuzukiSKamadaN: Establishment and characteristics of a gastric cancer cell line (HuGC-OOHIRA) producing high levels of G-CSF, GM-CSF, and IL-6: the presence of autocrine growth control by G-CSF. Am J Hematol1995; 49: 207–215.
14.
SchneiderMRHoeflichAFischerJRWolfESordatBLahmH: Interleukin-6 stimulates clonogenic growth of primary and metastatic human colon carcinoma cells. Cancer Lett2000; 151: 31–38.
15.
PiancatelliDRomanoPSebastianiPAdornoDCascianiCU: Local expression of cytokines in human colorectal carcinoma: evidence of specific interleukin-6 gene expression. J Immunother1999; 22: 25–32.
16.
ChomczynskiPSacchiN: Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem1987; 162: 156–159.
17.
HiranoTYasukawaKHaradaHTagaTWatanabeYMatsudaT: Complementary DNA for novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature1986; 324: 73–76.
18.
GuillaumeTSekhavatMRubinsteinDBHamdanOSymannML: Transcription of genes encoding granulocyte-macrophage colony-stimulating factor, interleukin 3, and interleukin 6 receptors and lack of proliferative response to exogenous cytokines in non-hematopoietic human malignant cell lines. Cancer Res1993; 53: 3139–3144.
19.
WeberJYangJCTopalianSLParkinsonDRSchwartzentruberDSEttinghausenSE: Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies. J Clin Oncol1993; 11: 499–506.
20.
GazdarAFMinnaJD: Targeted therapies for killing tumor cells. Proc Natl Acad Sci U S A2001; 98: 10028–10030.
21.
HiranoTAkiraSTagaTKishimotoT: Biological and clinical aspect of interleukin 6. Immunol Today1990; 11: 443–449.
22.
JernbergHPetterssonMKishimotoTNilssonK: Heterogeneity in response to interleukin 6 (IL-6), expression of IL-6 and IL-6 receptor mRNA in a panel of established human multiple myeloma cell lines. Leukemia1991; 5: 255–265.
23.
LopezMMarocNKeranguevenFBardinFCourcoulMLavezziC: Coexpression of gene for interleukin 6 and its receptor without apparent involvement in proliferation of acute myeloid leukemia cells. Exp Hematol1991; 19: 797–803.
24.
WuCWWangSRChaoMFWuTCLuiWYP'engFK: Serum interleukin-6 levels reflect disease status of gastric cancer. Am J Gastroenterol1996; 91: 1417–1422.
25.
Tran-ThangCKruithofEKOLahmHSchusterWATadaMSordatB: Modulation of the plasminogen activation system by inflammatory cytokines in human colon carcinoma cells. Br J Cancer1996; 74: 846–852.
26.
De VitaFRomanoCOrdituraMGaliziaGMartinelliELietoE: Interleukin-6 serum level correlates with survival in advanced gastrointestinal cancer patients but is not an independent prognostic indicator. J Interferon Cytokine Res2001; 21: 45–52.
27.
NishimotoNOgataAShimaYTaniYOgawaHNakagawaM: Oncostatin M, leukemia inhibitory factor, and interleukin 6 induce the proliferation of human plasmacytoma cells via the common signal transducer, gp130. J Exp Med1994; 179: 1343–1347.
28.
OhtaniHSasanoN: Stromal cell changes in human colorectal adenomas and carcinomas. An ultrastructural study of fibroblasts, myofibroblasts, and smooth muscle cells. Virchows Arch A Pathol Anat Histopathol1983; 401: 209–222.
